Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Continuous vs Intermittent Yaz in PMDD
NCT00927095Phase 4Completed
- Sponsor
- University of North Carolina at Chapel Hill
- Start
- Jul 2008
- Primary completion
- Jul 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of ethinyl estradiol + drospirenone in Premenstrual Dysphoric Disorder (PMDD) (3 arms), sponsored by University of North Carolina at Chapel Hill. Primary endpoint: Pre-Post Change in Premenstrual Symptom Severity. Started Jul 2008; status: completed.
02
Drugs
ethinyl estradiol + drospirenone
03
Conditions
Premenstrual Dysphoric Disorder (PMDD)
Beyond the preview
Go deeper on NCT00927095.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00927095.